%0 Journal Article
%T Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis
%A Jeffrey T. Guptill
%A M. Chris Runken
%A Michael Eaddy
%A Orsolya Lunacsek
%A Rupali M. Fuldeore
%J Archive of "American Health & Drug Benefits".
%D 2019
%X Corticosteroids, plasma exchange, and intravenous immunoglobulin (IVIG) have been standard-of-care treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) for more than 2 decades. Despite guideline recommendations for best clinical practices, heterogeneity in patient presentation and the course of treatment for CIDP remains. There is limited literature regarding the real-world treatment patterns of and costs associated with CIDP
%K chronic inflammatory demyelinating polyneuropathy
%K CIDP
%K economic burden
%K healthcare costs
%K intravenous immunoglobulin
%K IVIG
%K plasma exchanges
%K steroids
%K treatment patterns
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611518/